CV Safety of Vildagliptin in HF Unclear

HFC 2013 — LISBON — The diabetes medication vildagliptin may be beneficial in patients with type 2 diabetes and heart failure, but its cardiovascular safety is uncertain, a placebo-controlled trial showed.


< Back to Listings